Blog Posts - Mesothelioma



Swedish Mesothelioma Rates Unaffected By Asbestos Ban

The asbestos ban instituted in Sweden more than 30 years ago had still not had any measurable impact on the incidence ofmalignant mesothelioma in the country as of 2009.That is the conclusion reached by researchers at Sweden’s I...
by Mesothelioma Blog Article on Dec 2, 2016

Asbestos-Related T-Cell Changes Help Explain Mesothelioma Developmen

Researchers in Japan have taken another step toward understanding how asbestos causes malignant mesothelioma.Exposure to airborne asbestos fibers is the leading cause of malignant mesothelioma worldwide, but sc...
by Mesothelioma Blog Article on Dec 2, 2016

New Clinical Trial Aims to Create Bioresource for Improved Mesothelioma Diagnosis

New Clinical Trial Aims to Create Bioresource for Improved Mesothelioma DiagnosisMalignant mesothelioma is not only one of the rarest and most difficult-to-treat cancers. It is also among the hardest to diagnose.The challenge of diagno...
by Mesothelioma Blog Article on Dec 2, 2016

Psychological Needs of Mesothelioma Patients Differ from Lung Cancer

New research suggests that, even though pleural mesothelioma is considered a type of lung cancer, people with the asbestos cancer are likely to face some different stresses and concerns from lung cancer patients.Pleural mesothelio...
by Mesothelioma Blog Article on Dec 2, 2016

New Mesothelioma Immunotherapies Target Key Protein

The cell-surface glycoprotein mesothelin is poised to be a key part of several new immunotherapy approaches for the treatment of malignant pleural mesothelioma, a treatment-resistant cancer caused by asbestos.A team of top mesothe...
by Mesothelioma Blog Article on Dec 2, 2016

Platelet Count May be an Effective Tool for Mesothelioma Prognosis

A high platelet count may not bode well for people battlingmalignant pleural mesothelioma.New evidence suggests that people who have a high concentration of platelets in their blood prior to the start of mesothelioma treatmen...
by Mesothelioma Blog Article on Dec 2, 2016

Multi-Modal Mesothelioma Treatment Leads to Three-Year Survival

There has been some encouraging news this month for patients suffering from an aggressive form of lung cancer called malignant pleural mesothelioma. New research suggests that, even in patients with advanced mesothelioma, long-term survival...
by Mesothelioma Blog Article on Dec 2, 2016

Study Finds Chemotherapy Maximizes Odds of Mesothelioma Survival

A large US study of mesothelioma patients confirms what other studies have suggested: Mesothelioma patients who havechemotherapy live longer than those who don’t, and multimodal therapy is the best way to improve overall mesothe...
by Mesothelioma Blog Article on Dec 2, 2016

Mesothelioma Risk Among Seaman and Sailors Still Hard to Quantify

Thousands of people who worked aboard commercial ships may be at higher risk for developing malignant mesothelioma.Unfortunately, although the mesothelioma risk for merchant seamen has been acknowledged since the 1970s, there...
by Mesothelioma Blog Article on Dec 2, 2016

Measuring Mesothelioma Treatment Response with Biomarkers

Malignant pleural mesothelioma is notoriously difficult to treat and doctors often have to try different treatment combinations to produce a response. But how can they know if a particular treatment strategy is working?A team of researchers...
by Mesothelioma Blog Article on Dec 2, 2016

Treatments to prolong life for mesothelioma patients closer

Researchers have uncovered a strange way that asbestos-related tumours grow, which could pave the way towards better treatments. The scientists at Adelaide’s Flinders University have found that malignant mesothelioma tumours are able to transfo...
by AsbestosHUB on Nov 15, 2016

New Paradigms in the Treatment of Mesothelioma and NSCLC: An Overview by Fred Hirsch

Dr. Haffizulla: Welcome to PracticeUpdate. I’m Dr. Farzanna Haffizulla. Joining me today is Dr. Fred Hirsch, CEO of the International Association for the Study of Lung Cancer, and Professor of Medicine at the University of Colorado in Denver. Dr.
by AsbestosHUB on Nov 11, 2016

Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma

Malignant pleural mesothelioma shows marked cytoarchitectural diversity. The aim of the study was to evaluate how morphological phenotype impacted upon overall survival. 191 cases of malignant pleural mesothelioma with available follow-up were identi...
by AsbestosHUB on Nov 10, 2016

Residual fibre lung burden among patients with pleural mesothelioma who have been occupationally exposed to asbestos

Objectives  To evaluate the lungs asbestos fibres concentration in participants with malignant pleural mesothelioma (MPM) who have been occupationally exposed. Methods  The lung samples were obtained from pleuropneumonectomies or autopsies of 271 m...
by AsbestosHUB on Nov 8, 2016

Systemically administered RNAi molecule sensitizes malignant pleural mesothelioma cells to pemetrexed therapy

Pemetrexed (PMX) is a key drug for the treatment of malignant pleural mesothelioma (MPM). However, its therapeutic efficacy is cruelly restricted in many clinical settings by the over-expression of thymidylate synthase (TS) gene. Recently, we emphasi...
by AsbestosHUB on Nov 2, 2016

Arginine Deprivation for Malignant Pleural Mesothelioma

Arginine deprivation is a novel anticancer strategy in argininosuccinate synthetase 1 (ASS1)–negative tumors. In a multicenter, phase II trial, immunohistochemistry identified 68 patients with ASS1 deficiency among 201 patients with malignant pleur...
by AsbestosHUB on Oct 26, 2016

Scientists discover new option for treating malignant pleural mesothelioma

Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma. For the first time in the world, they were able to show in a preclinical study, both...
by AsbestosHUB on Oct 24, 2016

Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review

Abstract Background Desmoplastic malignant pleural mesothelioma (DMM) is rare histological subtype of diffuse malignant pleural mesothelioma (MPM), accounting for 5–10 % of cases. It has a poor prognosis, with direct invasion of the chest wall or...
by AsbestosHUB on Oct 19, 2016

What Is Mesothelioma – Overview Of Sorts, Leads to, Avoidance And Treatement Choices

What Is Mesothelioma The phrase Mesothelioma reasonably new to the medicine planet. It has been recognized only in the recent several years. So most of us might not even aware of the time period what is mesothelioma. If you node of course, go through...
by lifestyle9.xyz on Aug 26, 2016

Deteksi Dini Kanker Payudara Dengan Cara Komprehensif

Deteksi Dini Kanker Payudara Dengan Cara Komprehensif – Kanker payudara merupakan jenis penyakit yang harus ditangani secara medis. Jika seseorang telah positif terdeteksi mengidap kanker payudara namun tidak segera ditangani, maka penyebaranny...
by Informasi Kesehatan on May 22, 2016


Trending Topics

Close